Streptococcus suis and group B Streptococcus differ in their interactions with murine macrophages

FEMS Immunol Med Microbiol. 1998 Jul;21(3):189-95. doi: 10.1111/j.1574-695X.1998.tb01165.x.

Abstract

Streptococcus suis type 2 and group B Streptococcus type III (GBS) are important encapsulated bacterial species causing meningitis. In the present study we compared quantitatively the uptake and intracellular survival of S. suis type 2 and GBS type III with murine macrophages in non-opsonic conditions. The role of the capsule of both pathogens was also studied using previously obtained unencapsulated isogenic mutants. Encapsulated S. suis wild-type strain was practically not phagocytosed, while the unencapsulated mutant was easily ingested by macrophages. On the other hand, the well encapsulated GBS strain and its unencapsulated mutant were both phagocytosed in large numbers. Even if S. suis unencapsulated mutant showed a higher uptake rate than the parental strain, this value was always markedly lower than the numbers of ingested GBS strains. In addition, the intracellular survival of encapsulated and unencapsulated GBS strains was significantly higher than that of S. suis strains. These results suggest that interactions between GBS type III and S. suis type 2 with murine macrophages as well as the role of the capsule as an antiphagocytic factor are different for the two bacterial pathogens.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Bacterial Capsules / physiology*
  • Cell Line
  • Macrophages / immunology*
  • Macrophages / microbiology
  • Mice
  • Phagocytosis*
  • Streptococcus agalactiae / immunology
  • Streptococcus agalactiae / pathogenicity
  • Streptococcus agalactiae / physiology*
  • Streptococcus suis / immunology
  • Streptococcus suis / pathogenicity
  • Streptococcus suis / physiology*
  • Virulence